Amgen Opens Trial In Fight Over Neulasta Generic
By Carolina Bolado ( July 11, 2016, 11:27 PM EDT) -- Amgen Inc. began its pitch Monday to a Florida federal judge to block Canadian generics maker Apotex Inc. from making a copy of Amgen's blockbuster biologic Neulasta by arguing that the proposed biosimilar infringes a patent designed for industrial-scale protein production....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.